Search results for “Diastereomer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 17,449 patents, we discovered top 474 key players by total patent application. F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, Les Laboratoires Servier SAS are dominant in this area. They take 17.67% of the total patent filing.
Switzerland
Patent: 1,325
Rheinland-Pfalz, Germany
Patent: 1,078
France
Patent: 681
Austria
Patent: 537
New York, United States
Patent: 536
Ohio, United States
Patent: 510
Sweden
Patent: 375
Nordrhein-Westfalen, Germany
Patent: 337
France
Patent: 326
Richter Gedeon Nyrt
undefined undefined
Patent: 222
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 129 patents, we discovered top 15 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Endogena Therapeutics, Inc., TOLREMO therapeutics AG are active in this area.
STARTUP
France
Patent: 49
STARTUP
California, United States
Patent: 18
STARTUP
ZURICH, Switzerland
Patent: 16
STARTUP
Sichuan Sheng, China
Patent: 15
STARTUP
Guangdong Sheng, China
Patent: 12
STARTUP
California, United States
Patent: 4
STARTUP
Hong Kong SAR, China
Patent: 3
STARTUP
Massachusetts, United States
Patent: 3
STARTUP
Hubei Sheng, China
Patent: 3
STARTUP
Aria Pharmaceuticals, Inc.
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,971 patents applied in the last 5 years. We discover 426 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Richter Gedeon Nyrt, Hualing Pharmaceutical Technology (Shanghai) Co Ltd take 20.04% of patent filing during this period.
Switzerland
Patent: 195
Richter Gedeon Nyrt
undefined undefined
Patent: 117
Shanghai Shi, China
Patent: 83
Shanghai Shi, China
Patent: 78
New York, United States
Patent: 64
Gujarat, India
Patent: 43
France
Patent: 41
Jiangsu Sheng, China
Patent: 40
China
Patent: 29
Shanghai Shi, China
Patent: 29
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,971 patents in last 5 years, we discover 287 new entrants. Hualing Pharmaceutical Technology (Shanghai) Co Ltd, Endogena Therapeutics, Inc., Shanghai ETERN BioPharma Co. Ltd. are the most active new entrants in this area.
Shanghai Shi, China
Patent: 83
STARTUP
California, United States
Patent: 18
Shanghai ETERN BioPharma Co. Ltd.
Shanghai Shi, China
Patent: 17
STARTUP
ZURICH, Switzerland
Patent: 16
France
Patent: 16
STARTUP
Sichuan Sheng, China
Patent: 15
Guangdong Sheng, China
Patent: 15
Tokushima-ken, Japan
Patent: 13
Zhejiang Sheng, China
Patent: 13
Yinen Biopharmaceutical Suzhou Co Ltd.
Jiangsu Sheng, China
Patent: 13
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,568 patents, we discovered top 187 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, The European Molecular Biology Laboratory, President & Fellows of Harvard College are dominant in this area. They take 30.55% of the total patent filing.
Shanghai Shi, China
Patent: 141
Baden-Württemberg, Germany
Patent: 122
Massachusetts, United States
Patent: 36
North Carolina, United States
Patent: 34
Miyagi-ken, Japan
Patent: 27
Jiangsu Sheng, China
Patent: 24
Zhejiang Sheng, China
Patent: 22
Glasgow City, United Kingdom
Patent: 20
Ontario, Canada
Patent: 18
New York, United States
Patent: 17
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: